Table 1.

Classification of psychotropic drugs relevant to this study

Psychotropic drug group		Subgroup	Individual drugs
ADD		SSRI	escitalopram, citalopram, sertraline*
		SSNRI	venlafaxine, duloxetine*
		TCA	trimipramine, amitriptyline, doxepin*
		NaSSA	mirtazapine*
		MAO-I	tranylcypromine, moclobemide**
		other ADD	trazodone, bupropion, agomelatine*
APD	FGA	lp FGA	pipamperone, promethazine, prothipendyl, melperone*
		hp FGA	haloperidol, perazine, flupentixol**
	SGA		quetiapine, olanzapine, risperidone*
	TGA		aripiprazole*
HYPD		Z-drug	zopiclone, zolpidem*
TRD		benzodiazepine	lorazepam, diazepam, oxazepam*
AED			valproic acid, lamotrigine, and pregabalin*

ADD antidepressant drug, SSRI selective serotonin reuptake inhibitor, SSNRI selective serotonin–norepinephrine reuptake inhibitor, TCA tricyclic antidepressant, NaSSA noradrenergic and specific serotonergic antidepressant, MAO-I monoamine oxidase inhibitor, APD antipsychotic drug, FGA first-generation antipsychotic drug, lp low potency, hp high potency, SGA second-generation antipsychotic drug, TGA third-generation antipsychotic drug, HYPD hypnotic drug, TRD tranquilizing drug, AED antiepileptic drug

*only drugs used in the treatment of ≥ 2.5% of patients are listed

**because of very low overall utilization in these drug groups, drugs used in the treatment of ≥ 0.5% of patients are listed